Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature
Authors
Keywords
-
Journal
Journal of Clinical Hypertension
Volume 19, Issue 12, Pages 1377-1382
Publisher
Wiley
Online
2017-10-10
DOI
10.1111/jch.13097
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema
- (2017) Brittany T. Straka et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Meta-Analysis of Randomized Trials on the Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors in Patients ≥65 Years of Age
- (2016) Chirag Bavishi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Ecallantide for the Acute Treatment of Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema: A Multicenter, Randomized, Controlled Trial
- (2015) Lawrence M. Lewis et al. ANNALS OF EMERGENCY MEDICINE
- Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance Database
- (2015) Charles Faisant et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Effect of C1-Esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema
- (2015) Jens Greve et al. LARYNGOSCOPE
- A Randomized Trial of Icatibant in ACE-Inhibitor–Induced Angioedema
- (2015) Murat Baş et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors
- (2013) Daniel Caldeira et al. American Journal of Cardiovascular Drugs
- Propensity Score Methods for Confounding Control in Nonexperimental Research
- (2013) M. Alan Brookhart et al.
- Prise en charge des angiœdèmes induits par les inhibiteurs de l’enzyme de conversion de l’angiotensine : recommandations du Centre de référence national des angiœdèmes
- (2013) A. Nosbaum et al. REVUE DE MEDECINE INTERNE
- Meta-Analysis of Randomized Trials of Angioedema as an Adverse Event of Renin–Angiotensin System Inhibitors
- (2012) Harikrishna Makani et al. AMERICAN JOURNAL OF CARDIOLOGY
- Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States Adults With Hypertension
- (2012) Qiuping Gu et al. CIRCULATION
- Fresh Frozen Plasma for Progressive and Refractory Angiotensin-Converting Enzyme Inhibitor-induced Angioedema
- (2012) Getaw Worku Hassen et al. JOURNAL OF EMERGENCY MEDICINE
- Angiœdème bradykinique secondaire aux inhibiteurs de l’enzyme de conversion : instaurer le traitement en préhospitalier
- (2011) N. Javaud et al. ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION
- Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema
- (2011) Laura Beltrami et al. JOURNAL OF HYPERTENSION
- USE OF ANGIOTENSIN RECEPTOR BLOCKERS AFTER ANGIOEDEMA WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR
- (2010) Bret R. Haymore et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Therapeutic Efficacy of Icatibant in Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Case Series
- (2010) Murat Bas et al. ANNALS OF EMERGENCY MEDICINE
- Increased Incidence of Angioedema with ACE Inhibitors in Combination with mTOR Inhibitors in Kidney Transplant Recipients
- (2010) M. Duerr et al. Clinical Journal of the American Society of Nephrology
- Treatment of angiotensin-converting enzyme inhibitor–related angioedema with the bradykinin B2 receptor antagonist icatibant
- (2010) Peter W. Schmidt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema
- (2009) Nancy J. Brown et al. HYPERTENSION
- Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme Inhibitors
- (2008) Donald R. Miller et al. HYPERTENSION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started